Background {#Sec1}
==========

Hypertensive pregnancy disorders are a set of pregnancy-specific systemic diseases with a unique pathophysiology \[[@CR1]--[@CR5]\]. There are three main types of the disease: gestational hypertension, pre-eclampsia-eclampsia, and superimposed pre-eclampsia. Preeclampsia is a multisystem disorder accompanied by the new onset of hypertension and end-organ dysfunction with or without proteinuria. The critical conditions of hypertensive pregnancy disorders include eclampsia, hemolysis, elevated liver enzymes, low platelet counts, and disseminated intravascular coagulopathy \[[@CR6]--[@CR9]\]. Hypertensive pregnancy disorders are critical risk factors for pregnancy-associated stroke \[[@CR10]\]. They affect approximately 5% of pregnant women and increase the risk of pregnancy-associated cerebrovascular disease during the intrapartum and postpartum periods \[[@CR11]--[@CR14]\]. Cerebrovascular dysfunction related to hypertensive pregnancy disorders can lead to stroke, cerebral edema, seizures, and maternal mortality \[[@CR10], [@CR15], [@CR16]\].

A recent study revealed that although women were more likely to survive after stroke, poorer recovery was noted \[[@CR17]\]. However, most women did not know they were facing the risk of stroke. According to the JAMA guidelines, an estimated 425,325 new or recurrent strokes occur in women in the United States each year, representing approximately 53.5% of the stroke population. In 2010, women accounted for approximately 60% of stroke-related deaths (77,109 of 129,476 deaths). Approximately 3.8 million women live after having a stroke in the United States \[[@CR18]\]. Stroke is also the third-leading cause of death in Taiwan, and the mortality rate of stroke was 7.2% in 2012 \[[@CR19]\]. Based on the 1994 National Health Interview Survey, women accounted for approximately 46% of the stroke population in Taiwan \[[@CR20]\]. The related risk factors for stroke included hypertension, diabetes, hyperlipidemia, obesity, atrial fibrillation, and smoking \[[@CR21]--[@CR25]\].

However, few studies have mentioned the association between stroke not occurring during pregnancy or the postpartum period and hypertensive pregnancy disorders \[[@CR26]--[@CR29]\]. Thus, our study determined the risk of future stroke in women in Taiwan with hypertensive pregnancy disorders.

Methods {#Sec2}
=======

Data sources {#Sec3}
------------

The National Health Insurance program was implemented in 1995 in Taiwan, and the National Health Insurance Research Database (NHIRD) records the medical information of all insured people. The database includes approximately 23.74 million people in Taiwan, and it obtained a coverage rate of approximately 99.6% in 2009 \[[@CR30], [@CR31]\]. For study purposes, from 1 million individuals randomly selected as subjects obtained from the NHIRD, we created a small database. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) was used for the diagnostic and treatment codes in the NHIRD. With the permission of the National Health Research Institute, our study was able to use the databank. This study was granted approval by the Institutional Review Board of Tri-Service General Hospital (TSGHIRB No. 1--105--05-142).

Study design and sampled participants {#Sec4}
-------------------------------------

This study was conducted with a retrospective case-control design with outpatient and inpatient data. We collected our data from January 1, 2000 to December 31, 2013. Among the 989,753 individuals, 43,675 individuals were diagnosed with hypertensive pregnancy disorders (ICD-9 codes 642.0 to 642.9) prior to the index date. The patients were excluded if they met one of the following criteria: diagnosed with hypertensive pregnancy disorders before the index date, diagnosed with one stroke episode before tracking, aged \< 12 years, and male sex. At the end of the study, the case group comprised 41,870 individuals. A control group matched by index day and age with propensity scores was enrolled at a 3:1 ratio. The same exclusion criteria as that used for the case group was implemented, and the controls did not have hypertensive pregnancy disorder episodes in the study period; 125,610 individuals comprised the control group. The tracking event refers to the occurrence of stroke, and tracking continued until December 31, 2013. Individuals with any diagnoses of cerebrovascular disease (ICD-9 codes: 436.0 to 436.9 and 437.0 to 437.9) were defined as being diagnosed with stroke (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1The flowchart of study sample selection from the National Health Insurance Research Database in Taiwan

Outcome measures {#Sec5}
----------------

All study participants were followed from the index date until the onset of stroke (ICD-9 codes: 436.0 to 436.9 and 437.0 to 437.9), withdrawal from the insurance program, or the end of 2013. We eliminated peripartum strokes and postpartum strokes within 3 months (Table S3).

Covariates {#Sec6}
----------

The covariates were age group, area of residence, urbanization level of residence and annual income. The age group was separated into 12--19, 20--29, 30--39, and [\>]{.ul} 40 years. The area of residence was divided into northern, central, southern, and eastern regions, as well as surrounding islands. The urbanization level of residence was defined based on multiple indicators of development. Level 1 was defined as a population \> 1,250,000, with more political, economic, cultural and metropolitan development. Level 2 was a population between 500,000 and 1,249,999. Level 4 was populations less than 149,999, and level 3 was in between levels 2 and 4. The annual income in the United States Dollar (USD) was separated into three class intervals: \< 7200, 7200 to 13,999, and ≥ 14,000. Regarding the related comorbidities, we included hyperlipidemia (ICD-9 code: 272), diabetes mellitus (DM) (ICD-9 code: 250), heart disease (ICD-9 codes: 410--429), hypertension (HTN) (ICD-9 codes: 401--405), chronic kidney disease (CKD) (ICD-9 codes: 274.1, 403--404, 440.1, 442.1, 447.3, 572.4, 580--589, 642.1, and 646.2) and obesity (ICD-9 code: 278).

Statistical analysis {#Sec7}
--------------------

We conducted the analyses using SPSS 20 software (SPSS, Inc., Chicago, IL, USA). Descriptive statistics were used for basic information, including percentages, average values, and standard deviations.

Differences in the distribution of age, insurance premium, sex, season, location, urbanization level, comorbidities, and level of hospital between the two groups and between subjects with and without stroke were compared using the chi-square test. The Cox proportional hazards regression model was also applied to assess the influence of hypertensive pregnancy disorders on the risk of stroke. The relevant hazard ratios (HRs) and 95% confidence intervals (CIs) are presented. The difference in stroke risk between the two groups was estimated by the Kaplan-Meier method with the log-rank test. All results were statistically significant if the two-tailed *p* value was less than 0.05.

Results {#Sec8}
=======

This study examined 41,870 patients with hypertensive pregnancy disorders and 125,610 controls. At the 13-year follow-up, the cumulative incidence of stroke was 0.47% (198/41,870 individuals) in patients with hypertensive pregnancy disorders and 0.56% (698/125,610 individuals) in patients without hypertensive pregnancy disorders (Fig. [1](#Fig1){ref-type="fig"} and Table S[1](#MOESM1){ref-type="media"}). The Kaplan-Meier analysis indicated that patients with hypertensive pregnancy disorders had a significantly higher risk of developing stroke than did patients without hypertensive pregnancy disorders (log-rank test *P \<* 0.001) (Fig. [2](#Fig2){ref-type="fig"}). Strokes that occurred during the pregnancy and within 3 months postpartum were eliminated. These strokes were only a small portion of the total burden of disease (Table S3). Fig. 2Kaplan-Meier assessment of cumulative risk of stroke among females aged 12 and over stratified by hypertensive pregnancy disorders with log-rank test

In the 13th year of follow-up, the case group was more likely to develop stroke than the control group (*p* \< 0.001). At the end of follow-up, compared to the controls, patients with hypertensive pregnancy disorders tended to be younger in age (35.49 years old vs. 36.71 years old; *p* \< 0.001), have lower insurance premiums (95.48% vs. 94.77%; *p* \< 0.001) and have higher rates of diabetes mellitus (2.78% vs. 1.42%; *p* \< 0.001), HTN (3.29% vs. 1.37; *p* \< 0.001), and obesity (0.14% vs. 0.06; *p* = 0.001). Compared to the controls, more patients with hypertensive pregnancy disorders were treated in the hospital center (32.72% vs. 26.89%) and regional hospital (37.65% vs. 32.53%) (*P* \< 0.001) (Table [1](#Tab1){ref-type="table"}). Table 1Characteristics of the study population in regard to the endpointHypertensive pregnancy disordersTotalWithWithout***P***Variablesn%n%n%**Total**167,48041,87025.00125,61075.00**Stroke subgroup**\< 0.001 Without166,58499.4741,67299.53124,91299.44 Acute, but ill-defined, cerebrovascular disease2010.12800.191210.10 Other and ill-defined cerebrovascular disease6950.411180.285770.46**Age (years)**36.41 ± 7.0735.49 ± 6.4436.71 ± 7.28\< 0.001**Age group (years)**\< 0.001 12--1916450.984181.0012270.98 20--2948,36328.8813,19131.5035,17228.00 30--3990,91354.2822,21253.0568,70154.69 40--4924,79014.80566613.5319,12415.22 ≧5017691.063830.9113861.10**Insurance premium (USD)**\< 0.001  \< 7200159,02294.9539,97995.48119,04394.77 7200-13,99972224.3115113.6157114.55  ≥ 14,00012360.743800.918560.68**DM**29501.7611652.7817851.42\< 0.001**HTN**30961.8513793.2917171.37\< 0.001**Hyperlipidemia**8930.533120.755810.460.224**Obesity**1290.08590.14700.060.001**Heart disease**27081.626841.6320241.610.892**CKD**13940.833770.9010170.810.794**Season**\< 0.001 Spring36,20621.62945422.5826,75221.30 Summer47,38928.3010,26524.5237,12429.55 Autumn41,47824.7711,10426.5230,37424.18 Winter42,40725.3211,04726.3831,36024.97**Location**\< 0.001 Northern Taiwan67,38840.2417,25441.2150,13439.91 Middle Taiwan43,55926.0110,13424.2033,42526.61 Southern Taiwan40,12823.9610,00423.8930,12423.98 Eastern Taiwan15,4139.2041019.7911,3129.01 Surrounding islands9920.593770.906150.49**Urbanization level**\< 0.001 1 (The highest)63,43137.8715,29736.5348,13438.32 275,77045.2419,78447.2555,98644.57 310,9556.5421115.0488447.04 4 (The lowest)17,32410.34467811.1712,64610.07**Level of care**\< 0.001 Hospital center47,47628.3513,70132.7233,77526.89 Regional hospital56,62133.8115,76537.6540,85632.53 Local hospital63,38337.8512,40429.6350,97940.59*P:* Chi-square/Fisher exact test for categorical variables and t-test for continuous variables

The Cox regression analysis of the factors associated with the risk of stroke showed that the crude HR was 2.704 (95% CI = 2.326--3.144, *P \<* 0.001). After adjusting for the season, the urbanization level of residence and monthly income, the adjusted HR was 2.134 (95% CI = 1.817--2.505, *P \<* 0.001). Compared with younger women (aged 12--19 years old), for women between 20 and 29 and 30--39 years old, the adjusted HRs were 1.306 (*P* \< 0.001) and 1.215 (*P* = 0.011), respectively. Our results indicated that patients with hypertensive pregnancy disorders had a 2.134-fold higher risk of developing stroke than did individuals without hypertensive pregnancy disorders (Table [2](#Tab2){ref-type="table"} and S2). Those with diabetes mellitus (DM) (*P* \< 0.001), hypertension (HTN) (*P* \< 0.001), hyperlipidemia (*P* \< 0.001), heart disease (*P* \< 0.001), and chronic kidney disease (CKD) (*P* \< 0.001) had a higher risk of developing stroke than those without these comorbidities. A higher incidence of stroke development was observed among hypertensive pregnancy disorder patients who visited the hospital center than among those who visited the local hospital (Table [2](#Tab2){ref-type="table"}). Table 2Factors associated with stroke according to Cox regressionVariablesCrude HR95% CI95% CI***P***Adjusted HR95% CI95% CI***P***Hypertensive pregnancy disorders WithoutReferenceReference With2.7042.3263.144\< 0.0012.1341.8172.505\< 0.001**Age group (years)** 12--19ReferenceReference 20--291.1051.0481.2610.0291.3061.1371.942\< 0.001 30--391.1291.0601.2780.0241.2151.0871.3200.011 40--491.0940.4521.4130.3671.2850.9131.2480.218 ≧500.3410.1581.0120.0550.5370.0841.0650.066**Insured premium (USD)**  \< 7200ReferenceReference 7200-13,9991.4580.1492.2710.2241.9660.5222.5820.249  ≥ 14,0001.7550.4472.4250.1242.6500.1574.7620.179**DM**4.1903.5324.970\< 0.0011.4491.2771.874\< 0.001**HTN**7.6966.7428.903\< 0.0014.2743.6165.050\< 0.001**Hyperlipidemia**8.1756.55910.177\< 0.0013.0612.4153.886\< 0.001**Obesity**2.6070.9106.4900.0671.1150.4182.9950.584**Heart disease**4.0273.3534.837\< 0.0012.1361.7612.589\< 0.001**CKD**4.4443.4665.699\< 0.0012.3561.8293.041\< 0.0014 (The lowest)ReferenceReference**Level of care** Hospital center1.8761.5922.213\< 0.0011.6311.3491.972\< 0.001 Regional hospital1.2091.0201.4360.0112.1330.8851.2510.242 Local hospitalReferenceReference*HR* hazard ratio, *CI* confidence interval, Adjusted HR: Adjusted for variables listed in the tableAdjusted variables: geographical area of residence, urbanization level of residence, and season

The incidence and HR of stroke in populations with or without hypertensive pregnancy disorders relative to those in controls are listed in Table [3](#Tab3){ref-type="table"}. After adjusting for all the other variables, regardless of the other factors, compared with patients without hypertensive pregnancy disorders, those with hypertensive pregnancy disorders had a rate of 1.21 per 1000 patient-years vs. 1.06 per 1000 patient-years in those without gestational hypertension and an HR of stroke that was 2.134-fold (*P* \< 0.001) higher than that of those without gestational hypertension (Table [3](#Tab3){ref-type="table"} and Fig. [3](#Fig3){ref-type="fig"}). Table 3Factors associated with stroke stratified by variables listed in the table by using Cox regressionHypertensive pregnancy disordersWithWithout *(Reference)*RatioAdjusted HR95% CI95% CI***P***StratifiedEventsPYsRate (per 10^**5**^ PYs)EventsPYsRate (per 10^**5**^ PYs)**Total**198163,208.79121.32698654,982.30106.571.1382.1341.8172.505\< 0.001**Age group (years)** 12--192271.80735.833589.64508.781.4462.7112.3083.182\< 0.001 20--296432,914.98194.448780,370.21108.251.7963.3672.8673.953\< 0.001 30--399777,048.17125.90303238,213.86127.200.9901.8551.5802.178\< 0.001 40--493418,003.53188.85294137,974.59213.080.8861.6611.4151.950\< 0.001 ≧50134,970.302.8611197,833.995.560.5140.9640.8211.1320.276**Insured premium (USD)**  \< 7200191125,404.75152.31688466,665.85147.431.0331.9371.6492.273\< 0.001 7200-13,99952344.91213.2388975.4289.132.3924.4843.8185.264\< 0.001  ≥ 14,000235,459.135.642179,341.031.125.0589.4818.07311.129\< 0.001**DM**208430.94237.225642,672.99131.231.8083.3892.8853.978\< 0.001**HTN**5413,688.23394.509935,172.46281.471.4022.6272.2373.084\< 0.001**Hyperlipidemia**131980.06656.55428226.33510.561.2862.4112.0522.830\< 0.001**Obesity**1477.68209.3512343.4542.674.9069.1967.83010.795\< 0.001**Heart disease**145039.75277.797533,325.22225.051.2342.3141.9702.716\< 0.001**CKD**62500.94239.914023,770.74168.271.4262.6732.2763.137\< 0.001**Season** Spring5230,039.53173.11146109,482.26133.351.2982.4332.0722.856\< 0.001 Summer4032,853.28121.75175126,710.16138.110.8821.6531.4071.940\< 0.001 Autumn6137,155.10164.18191132,193.49144.491.1362.1301.8142.500\< 0.001 Winter4563,160.8771.25186286,596.3964.901.0982.0581.7522.416\< 0.001**Urbanization level** 1 (The highest)7543,701.39171.62225153,595.67146.491.1722.1961.8702.578\< 0.001 28357,996.46143.11294210,128.07139.911.0231.9171.6332.251\< 0.001 31610,060.20159.044046,748.2985.561.8593.4842.9674.090\< 0.001 4 (The lowest)2451,450.7546.65139244,510.2756.850.8211.5381.3101.806\< 0.001**Level of care** Hospital center9643,471.31220.84301142,056.49211.891.0421.9541.6632.293\< 0.001 Regional hospital6450,293.76127.25215183,114.94117.411.0842.0321.7302.385\< 0.001 Local hospital3869,443.7254.72182329,810.8755.180.9921.8591.5832.182\< 0.001*PYs* Person-years; *Adjusted HR* Adjusted hazard ratio: Adjusted for the variables listed in Table [3](#Tab3){ref-type="table"}; *CI* confidence intervalFig. 3Factors of stroke stratified by hypertensive pregnancy disorder subgroup using Cox regression

When we analyzed factors related to stroke and stratified patients by hypertensive pregnancy disorder subgroup using Cox regression, the risk of stroke was 3.412-fold (95% CI = 2.905--4.005) higher in patients with a benign essential hypertension-complicated pregnancy (ICD-9: 642.0) (*P* \< 0.001), and the rate was 1.9388 per 1000 patient-years. The risk of stroke was 2.130-fold (95% CI = 1.814--2.500) higher in patients with severe preeclampsia (ICD-9: 642.5) (*P* \< 0.001), and the rate was 1.2105 per 1000 patient-years. The risk of stroke was 4.584-fold (95% CI = 3.903--5.380) higher in patients with eclampsia (ICD-9: 642.6) (*P* \< 0.001), and the rate was 2.6048 per 1000 patient-years. The risk of stroke was 3.117-fold (95% CI = 2.654--3.659) higher in patients with pre-eclampsia or eclampsia superimposed on pre-existing hypertension (ICD-9: 642.7) (*P* \< 0.001), and the rate was 1.7712 per 1000 patient-years. The risk of stroke was 2.676-fold (95% CI = 2.279--3.141) higher in patients with a hypertension-complicated pregnancy (ICD-9: 642.9) (*P* \< 0.001), and the rate was 1.5208 per 1000 patient-years (Fig. [3](#Fig3){ref-type="fig"}).

Discussion {#Sec9}
==========

Hypertensive pregnancy disorders are the most common cause of hypertension in pregnant women \[[@CR5]\]. They are classified into 3 categories: gestational hypertension, preeclampsia-eclampsia, and superimposed preeclampsia \[[@CR32]\]. Women with chronic high blood pressure experience more complications during pregnancy \[[@CR12]\]. High blood pressure may also lead to other long-term health problems after pregnancy. Stroke is an undesirable condition among younger women, as it is considered to have adverse effects on personal status, families and society. Health issues not only affect women but also demand major changes of the whole family. The incidences of both early- and late-onset preeclampsia increased in Taiwan from 2001 to 2014, especially for early-onset disease \[[@CR33]\]. Preeclampsia has become an important issue to be aware of.

Studies show that hypertensive pregnancy disorders not only affect the pregnancy period but also increase the risk of cardiovascular disease later in life \[[@CR34], [@CR35]\]. Pregnancy-related hypertension is thought to be an important risk factor for both cerebrovascular disease and intracranial venous thrombosis in some studies \[[@CR36]\]. One study based on the general population during the intrapartum and postpartum periods in Taiwan revealed that preeclampsia/eclampsia are the two most common causes of intracranial hemorrhage and the three most common causes of cerebral infarction during the intrapartum and postpartum periods \[[@CR37]\].

In one cohort study in Sweden, the authors found that an increased risk of cardiovascular disease and cerebrovascular disease after hypertensive disease of pregnancy persisted in the older population \[[@CR21]\]. One study in Taiwan previously revealed that the respective adjusted relative risk of hemorrhagic and ischemic cerebrovascular disease after preeclampsia-eclampsia was much higher, regardless of whether it was within the first 3 days postpartum or within 1 year of the postpartum period \[[@CR38]\]. One retrospective cohort study based on the Utah Population Database also showed that women with hypertensive disease of pregnancy have increased mortality risk, particularly with respect to ischemic heart disease and cerebrovascular disease \[[@CR39]\].

Our study revealed an important issue in hypertensive pregnancy disorders during pregnancy. Strokes that did not occur in the pregnancy and postpartum timeframes accounted for a main portion of the total burden of disease. Women with hypertensive disorders of pregnancy are at significant risk for stroke at a relatively young age. Interval hypertension control and follow-up after pregnancy is likely to be important. Patient education on future stroke issues, exercise and diet counseling could be involved in the postpartum period. Women with a history of hypertensive pregnancy disorders should be candidates for risk modification, including HTN control, lipid management, and weight management.

Our study included a well-established dataset using population-based research with a large sample size, and we explored hypertensive pregnancy disorders as a risk factor for developing stroke. Nevertheless, there are still some limitations of this study. First, although the coding of the NHIRD has not been validated in the recording of all diseases, there were no reports regarding the coding of the severity of stroke or the location of stroke. Data on blood pressure during pregnancy and the control status of hypertensive pregnancy disorders were also unavailable in the database. For these reasons, the effect of hypertensive pregnancy disorders on the severity of stroke or the site of stroke could not be analyzed in detail. Second, the NHIRD registry cannot provide detailed information regarding patients' laboratory results, lifestyles, past history or family history, and we believe some of these factors, such as smoking, may increase the risk of stroke. Third, given that the population comprises younger females, there might be an underlying disease of the brain that was not noted before, and although the population may be small, we believed that it could also contribute to the increased incidence of stroke \[[@CR40]\]. Fourth, there are also some factors that may contribute to stroke, such as autoimmune diseases \[[@CR41]--[@CR43]\], thyroid disease \[[@CR43]--[@CR45]\], oral contraceptive use \[[@CR46]--[@CR48]\], and infectious diseases \[[@CR49]--[@CR51]\], none of which were discussed in this study.

Conclusions {#Sec10}
===========

Our study provided evidence of the increased risk of stroke in patients with hypertensive pregnancy disorders. Compared with those without hypertensive pregnancy disorders, the patients who had experienced such disorders had a 2.134-fold (*P* \< 0.001) higher risk of developing stroke in the future. The occurrence of stroke in younger women is an important issue, especially among those who are in the childbearing stage. The results from this study will provide physicians with strong proof of the need for the cautious treatment of patients with hypertensive pregnancy disorders and awareness of possible future stroke problems.
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**Additional file 1: Table S1.** Distribution of hypertensive pregnancy disorders. **Table S2.** Factors (season, location, urbanization level) associated with stroke using Cox regression. **Table S3.** Sensitivity of factors associated with stroke by using Cox regression.
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